Lawmakers impatient with the lack of progress on a key health care issue — the long-debated need for changes to what’s known ...

The Health Resources and Services Administration posted on its website that it had approved eight drug company plans for participation in the 340B Rebate Model Pilot Program with a start date of Jan.

Lawmakers across the country are working through bills written to shield a growing source of revenue for hospital systems and ...

Drugs that will be subject to rebates in 340B next year include Bristol Myers Squibb’s Eliquis, Johnson & Johnson’s Stelara ...

The US Health Resources and Services Administration (HRSA) has approved nine drugs for a pilot testing a new rebate model ...

FAH rebuts Senate hearing claims, clarifying taxpaying hospitals do not benefit from the 340B drug pricing program discounts.

The US Health Resources and Services Administration (HRSA) revealed the initial nine drugs to be included in the 340B rebate model. The decision comes after pharma companies filed suit in regard to ...

This approach would aim to raise the same amount of revenue that was previously generated by covered entities’ arbitrage of ...

Former Congressional Budget Office Director Dan Crippen argues the 340B discount program is overdue for reform.

Guest essayist Juan-Paulo B. Afable, CEO of My Community Health Center in Canton, says Ohio lawmakers need to support ...

Kansas’ Jerry Moran is part of a bipartisan group of U.S. senators working to reduce large hospital networks’ fraud and abuse ...

AHA writes to express our strong support for this vital program that allows eligible hospitals to maintain, improve and expand access to essential services and medications for the patients and ...